loobobilly News: FDA Panel Endorses Gene Therapy For A Form Of Childhood Blindness

FDA Panel Endorses Gene Therapy For A Form Of Childhood Blindness Food and Drug Administration advisers unanimously recommended that the agency approve the first gene therapy for an inherited disease — a rare defect that causes blindness in children. Food and Drug Administration advisers unanimously recommended that the agency approve the first gene therapy for an inherited disease — a rare defect that causes blindness in children. Business
Food and Drug Administration advisers unanimously recommended that the agency approve the first gene therapy for an inherited disease — a rare defect that causes blindness in children.

Read more on NPR